Navigation Links
Tengion Appoints A. Brian Davis Chief Financial Officer
Date:8/2/2010

as.  "During her nearly six years with Tengion, Linda has played a defining role in the development of our finance function and was instrumental in our becoming a public company earlier this year.  We wish Linda and her family all the best in their new life abroad and we are grateful that she will remain with Tengion in the coming weeks to ensure a smooth transition," said Dr. Nichtberger.  

About Tengion

Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platform that enables us to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Our product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. Tengion commenced a Phase I clinical trial in the first half of 2010 for its lead product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal. Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment™ for the treatment of neurogenic bladder and is in pre-clinical development of its Neo-Kidney Augment™. Tengion has worldwide rights to its product candidates.


'/>"/>
SOURCE Tengion Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
2. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
3. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
4. Tengion Announces Second Closing of Series C Financing
5. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
6. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
7. CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
8. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
9. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
10. SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents
11. Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... solutions for drug discovery and related life ... consortium has chosen Genedata Selector as its ... (NGS) data. FUNGITECT is a European consortium ... fungal diseases via individualized anti-fungal drug therapies. ...
(Date:9/30/2014)... , Sept. 30, 2014  KemPharm, Inc., ... discovery and development of proprietary new molecular entity ... Patent and Trademark Office (USPTO) issued U.S. Patent ... entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl ... Making and Use Thereof." The patent, ...
(Date:9/30/2014)... MAR, Calif. , Sept. 30, 2014 ... for women,s health announces its receipt of a patent ... FemmyCycle menstrual cup has also received FDA clearance in ... Canada, and the CE in Europe. This patent is related ... conjunction with this issuance, the company is releasing FemmyCycle ...
(Date:9/30/2014)... The overall research objective was to ... and use. Most researchers outsource NGS technologies; however, ... within the next 12 months. Data accuracy and ... sequencing instruments. Disease-related research is the dominant use ... to surge, with half of the respondents planning ...
Breaking Biology Technology:FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2Global Next-generation Sequencing Trends 2
... Therapeutics (NYSE Amex: CXM ) today reported that the Company has received a letter ... the Company,s exchange listing compliance. , , , ... , , ... , , In the ...
... ... come when sorghum, sugar cane and other crops are considered , ... (PRWEB) July 7, 2010 -- Banning the agricultural ... to University of Chicago economist Don L. Coursey, Ph.D . , , ,Dr. Coursey ...
... July 7 DATATRAK International, Inc. (OTCQX: DATA), a ... the clinical trials industry, today announced that it privately placed ... per share with certain members of its Board of ... the private placement are restricted securities and are subject to ...
Cached Biology Technology:Cardium Regains Listing Compliance With NYSE Amex 2Cardium Regains Listing Compliance With NYSE Amex 3Cardium Regains Listing Compliance With NYSE Amex 4Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 2Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 3DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 3
(Date:9/30/2014)... Diego, have completed the first comprehensive numerical simulation of ... pixels in an image as data points for the ... researchers, led by J.S. Chen, the William Prager Professor ... at UC San Diego, presented their findings on the ... Pittsburgh this month. Chen also gave a keynote speech ...
(Date:9/30/2014)... Calif. The National Institutes of Health (NIH) ... today to develop an electrode array system that ... brain works through unprecedented resolution and scale. , ... to support President Obama,s BRAIN (Brain Research ... research effort to revolutionize our understanding of the ...
(Date:9/30/2014)... Fish can live in almost any aquatic environment on ... up many species are pushed to the limit. The ... could prove critical for how different species cope in ... the University of Gothenburg, published in the scientific journal ... Climate change continues apace thanks to increasing levels of ...
Breaking Biology News(10 mins):First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3Shape up quickly -- applies to fish, too! 2
... Amsterdam, NL, 21 August 2013 Metals such as ... processes. In recent years, studies have shown that these ... brains and some animal models of AD. Scientists are ... seen in AD or are indicative of other ongoing ...
... pollution involving soot that spreads from China over large ... fostering global warming comes from city traffic and ... with coal briquettes. That,s the conclusion of a study ... which resolves long-standing questions about sources of air pollution ...
... Monday following a big football game, fans of the ... and sugars, whereas supporters of the winning team opt ... Psychological Science , a journal of the Association ... that sport outcomes influence reckless driving, heart attacks, and ...
Cached Biology News:Elevated levels of copper in amyloid plaques associated with neurodegeneration in mouse models of AD 2For disappointed sports fans, defeats increase consumption of fat and sugar 2
...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
... Serum; U.S. sourced, ideal for ... quality; Low hemoglobin; Endotoxin: < ... of US origin; U.S. sourced, ... an uncompromising quality. Low hemoglobin ...
NEWBORN CALF SERUM AND PLASMA...
Biology Products: